Literature DB >> 21160087

High concentrations of pepsin in bronchoalveolar lavage fluid from children with cystic fibrosis are associated with high interleukin-8 concentrations.

P McNally1, E Ervine, M D Shields, B D Dimitrov, B El Nazir, C C Taggart, C M Greene, N G McElvaney, P Greally.   

Abstract

BACKGROUND: Gastro-oesophageal reflux is common in children with cystic fibrosis (CF) and is thought to be associated with pulmonary aspiration of gastric contents. The measurement of pepsin in bronchoalveolar lavage (BAL) fluid has recently been suggested to be a reliable indicator of aspiration. The prevalence of pulmonary aspiration in a group of children with CF was assessed and its association with lung inflammation investigated.
METHODS: This was a cross-sectional case-control study. BAL fluid was collected from individuals with CF (n=31) and healthy controls (n=7). Interleukin-8 (IL-8), pepsin, neutrophil numbers and neutrophil elastase activity levels were measured in all samples. Clinical, microbiological and lung function data were collected from medical notes.
RESULTS: The pepsin concentration in BAL fluid was higher in the CF group than in controls (mean (SD) 24.4 (27.4) ng/ml vs 4.3 (4.0) ng/ml, p=0.03). Those with CF who had raised pepsin concentrations had higher levels of IL-8 in the BAL fluid than those with a concentration comparable to controls (3.7 (2.7) ng/ml vs 1.4 (0.9) ng/ml, p=0.004). Within the CF group there was a moderate positive correlation between pepsin concentration and IL-8 in BAL fluid (r=0.48, p=0.04). There was no association between BAL fluid pepsin concentrations and age, sex, body mass index z score, forced expiratory volume in 1 s or Pseudomonas aeruginosa colonisation status.
CONCLUSIONS: Many children with CF have increased levels of pepsin in the BAL fluid compared with normal controls. Increased pepsin levels were associated with higher IL-8 concentrations in BAL fluid. These data suggest that aspiration of gastric contents occurs in a subset of patients with CF and is associated with more pronounced lung inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21160087     DOI: 10.1136/thx.2009.130914

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

1.  Identification of Helicobacter pylori VacA in human lung and its effects on lung cells.

Authors:  Shota Nakashima; Tomoyuki Kakugawa; Hirokazu Yura; Masaomi Tomonaga; Tatsuhiko Harada; Atsuko Hara; Shintaro Hara; Masayuki Nakano; Eiki Yamasaki; Noriho Sakamoto; Yuji Ishimatsu; Hajime Isomoto; Bernadette R Gochuico; Anthony F Suffredini; Hiroshi Mukae; Hisao Kurazono; Toshiya Hirayama; Joel Moss; Shigeru Kohno
Journal:  Biochem Biophys Res Commun       Date:  2015-03-25       Impact factor: 3.575

2.  Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis.

Authors:  Charles R Esther; Marianne S Muhlebach; Camille Ehre; David B Hill; Matthew C Wolfgang; Mehmet Kesimer; Kathryn A Ramsey; Matthew R Markovetz; Ian C Garbarine; M Gregory Forest; Ian Seim; Bryan Zorn; Cameron B Morrison; Martial F Delion; William R Thelin; Diane Villalon; Juan R Sabater; Lidija Turkovic; Sarath Ranganathan; Stephen M Stick; Richard C Boucher
Journal:  Sci Transl Med       Date:  2019-04-03       Impact factor: 17.956

3.  Diagnosing GORD in Respiratory Medicine.

Authors:  Chris J Timms; Deborah H Yates; Paul S Thomas
Journal:  Front Pharmacol       Date:  2011-07-22       Impact factor: 5.810

4.  Positive bronchoalveolar lavage pepsin assay associated with viral and fungal respiratory infections in children with chronic cough.

Authors:  Corey N Martin; Zhour Barnawi; Elizabeth Chorvinsky; Dhruv Pillai; Meagan Gatti; Maura E Collins; Gina M Krakovsky; Nancy M Bauman; Sona Sehgal; Dinesh K Pillai
Journal:  Pediatr Pulmonol       Date:  2021-05-13

5.  Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation.

Authors:  Gemma L Zeybel; Jeffrey P Pearson; Amaran Krishnan; Stephen J Bourke; Simon Doe; Alan Anderson; Shoaib Faruqi; Alyn H Morice; Rhys Jones; Melissa McDonnell; Mujdat Zeybel; Peter W Dettmar; Malcolm Brodlie; Chris Ward
Journal:  J Cyst Fibros       Date:  2016-07-27       Impact factor: 5.482

6.  Successful outcome following pneumonectomy in a teenage boy with cystic fibrosis: a case report.

Authors:  Zheyi Liew; Santosh Mallikarjuna; Asif Hasan; F Kate Gould; Su Bunn; Matthew F Thomas; Jim L Lordan; Christopher O'Brien; Malcolm Brodlie
Journal:  BMC Pulm Med       Date:  2017-01-13       Impact factor: 3.317

7.  The Detection of Bile Acids in the Lungs of Paediatric Cystic Fibrosis Patients Is Associated with Altered Inflammatory Patterns.

Authors:  Jose A Caparrós-Martín; Stephanie Flynn; F Jerry Reen; David F Woods; Patricia Agudelo-Romero; Sarath C Ranganathan; Stephen M Stick; Fergal O'Gara
Journal:  Diagnostics (Basel)       Date:  2020-05-06

8.  Bile acid aspiration in people with cystic fibrosis before and after lung transplantation.

Authors:  Malcolm Brodlie; Ali Aseeri; Jim L Lordan; Andrew G N Robertson; Michael C McKean; Paul A Corris; S Michael Griffin; Nigel J Manning; Jeffrey P Pearson; Christopher Ward
Journal:  Eur Respir J       Date:  2015-10-22       Impact factor: 16.671

9.  Bile Acid Signal Molecules Associate Temporally with Respiratory Inflammation and Microbiome Signatures in Clinically Stable Cystic Fibrosis Patients.

Authors:  Stephanie Flynn; F Jerry Reen; Jose A Caparrós-Martín; David F Woods; Jörg Peplies; Sarath C Ranganathan; Stephen M Stick; Fergal O'Gara
Journal:  Microorganisms       Date:  2020-11-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.